Xiaoxian Li

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 14

Top Topics

African American

Positive Breast Cancer

Endoplasmic Reticulum

Top Venues

Breast cancer research and treatment

Clinical cancer research : an official journal of the American Association for Cancer Research

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

The breast journal

This page only lists publications with an associated author ORCID identifier.

Publications

Di Ai, Gulisa Turashvili, Sandra Gjorgova Gjeorgjievski, Qun Wang, Abdulwahab M Ewaz, Yuan Gao, Thi Nguyen, Chao Zhang, Xiaoxian Li
Subspecialized breast pathologists have suboptimal interobserver agreement in Ki-67 evaluation using 20% as the cutoff. Breast cancer research and treatment (2023)
Di Ai, Gulisa Turashvili, Sandra Gjorgova Gjeorgjievski, Qun Wang, Abdulwahab M Ewaz, Yuan Gao, Thi Nguyen, Chao Zhang, Xiaoxian Li
Subspecialized breast pathologists have suboptimal interobserver agreement in Ki-67 evaluation using 20% as the cutoff. Breast cancer research and treatment 204 (2) (2023)
Di Ai, Gulisa Turashvili, Sandra Gjorgova Gjeorgjievski, Qun Wang, Abdulwahab M Ewaz, Yuan Gao, Thi Nguyen, Chao Zhang, Xiaoxian Li
Subspecialized breast pathologists have suboptimal interobserver agreement in Ki-67 evaluation using 20% as the cutoff. Breast cancer research and treatment 204 (2) (2023)
Kai Sun, Yitian Xu, Licheng Zhang, Polly A Niravath, Jorge G Darcourt, Tejal Patel, Bin S Teh, Andrew M Farach, Carlo Guerrero, Sunil Mathur, Mark A Sultenfuss, Nakul Gupta, Mary R Schwartz, Susan L Haley, Sindhu Nair, Xiaoxian Li, Thi Truc Anh Nguyen, Joseph D Butner, Joe E Ensor, Jaime A Mejia, Zhuyong Mei, E Brian Butler, Shu-Hsia Chen, Eric H Bernicker, Jenny C Chang
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Thi Truc Anh Nguyen, Lauren M Postlewait, Chao Zhang, Jane L Meisel, Ruth O'Regan, Sunil Badve, Kevin Kalinsky, Xiaoxian Li
Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer. Breast cancer research and treatment 192 (3) (2022)
Xiaoxian Li, Zhongliang Ma, Toncred M Styblo, Cletus A Arciero, Haibo Wang, Michael A Cohen
Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution. Breast cancer research and treatment 185 (3) (2020)
Rohit Bhargava, Nicole N Esposito, Siobhan M OʹConnor, Zaibo Li, Bradley M Turner, Ioana Moisini, Aditi Ranade, Ronald P Harris, Dylan V Miller, Xiaoxian Li, Harrison Moosavi, Beth Z Clark, Adam M Brufsky, David J Dabbs
Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (1) (2020)
Aidan C Li, Jing Zhao, Chao Zhao, Zhongliang Ma, Ramon Hartage, Yunxiang Zhang, Xiaoxian Li, Anil V Parwani
Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma. Breast cancer research and treatment 180 (2) (2020)
Zhongliang Ma, Cletus A Arciero, Toncred M Styblo, Haibo Wang, Michael A Cohen, Xiaoxian Li
Patients with benign papilloma diagnosed on core biopsies and concordant pathology-radiology findings can be followed: experiences from multi-specialty high-risk breast lesion conferences in an academic center. Breast cancer research and treatment 183 (3) (2020)
Jing Zhao, Jane Meisel, Yi Guo, Rita Nahta, Kung Lin Hsieh, Limin Peng, Zhimin Wei, Ruth O'Regan, Xiaoxian Li
Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies. Breast cancer research and treatment 183 (3) (2020)
Xiaoxian Li, Yiran Zhang, Jane Meisel, Renjian Jiang, Madhusmita Behera, Limin Peng
Validation of the newly proposed American Joint Committee on Cancer (AJCC) breast cancer prognostic staging group and proposing a new staging system using the National Cancer Database. Breast cancer research and treatment 171 (2) (2018)
Cameron Neely, Shuo You, Pia M Mendoza, Ritu Aneja, Aysegul A Sahin, Xiaoxian Li
Comparing breast biomarker status between routine immunohistochemistry and FISH studies and Oncotype DX testing, a study of 610 cases. The breast journal 24 (6) (2018)
Cletus A Arciero, Jing Yang, Limin Peng, Kevin C Ward, Ruth O'Regan, Aysegul A Sahin, Xiaoxian Li
African American patients with breast cancer have worse prognosis than white patients in certain subtypes and stages. Breast cancer research and treatment 166 (3) (2017)
Xiaoxian Li, Jing Yang, Limin Peng, Aysegul A Sahin, Lei Huo, Kevin C Ward, Ruth O'Regan, Mylin A Torres, Jane L Meisel
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer. Breast cancer research and treatment 161 (2) (2016)